Advertisement
Foghorn Therapeutics Inc. (FHTX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 7.72 |
| Open | 7.83 |
| Bid | 7.71 x 100 |
| Ask | 8.03 x 100 |
| Day's Range | 7.55 - 8.19 |
| 52 Week Range | 2.70 - 10.25 |
| Volume | |
| Avg. Volume | 160,845 |
| Market Cap | 435.85M |
| Beta (5Y Monthly) | 3.15 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.85 |
| Earnings Date | Nov 04, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.00 |
GlobeNewswireFoghorn Therapeutics to Participate in Three Upcoming Investor Conferences
CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced management's participation in the Jefferies London Healthcare Conference, the 7th Annual Evercore HealthCONx Conference, and the Citi Global Healthcare Conference. With an initial focus in oncology, Foghorn’s Gene Traffic Control® platform and re
Simply Wall St.Analysts Have Made A Financial Statement On Foghorn Therapeutics Inc.'s (NASDAQ:FHTX) Third-Quarter Report
Foghorn Therapeutics Inc. ( NASDAQ:FHTX ) just released its quarterly report and things are looking bullish. The...
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.